Haploidentical NK Cell Infusion in Malignant Melanoma

Clinical Trial ID NCT00846833

PubWeight™ 5.35‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00846833

Top papers

Rank Title Journal Year PubWeight™‹?›
1 NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 2013 2.39
2 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
3 Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective. Front Immunol 2014 0.95
4 Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy. Front Immunol 2016 0.78
Next 100